---
figid: PMC6156430__JCMM-22-4558-g002
figlink: /pmc/articles/PMC6156430/figure/jcmm13669-fig-0002/
number: Figure 2
caption: A schematic diagram of the molecular mechanisms underlying K63‐linked polyubiquitination
  and cardiac hypertrophy. In TNF‐α pathway, TNFR recruits its adaptor protein TRADD
  in response to binding of TNF‐α. TRADD further recruits TRAF2, TRAF5 and RIP1 to
  the receptor complex. TRAF2/5‐mediated K63 polyubiquitination of RIP1 further recruits
  TAB2 and TAK1 in the cytoplasm, which activates TAK1 by phosphorylation. The activated
  RIP1‐TAK1‐TAB2 complex subsequently promotes activation of MEKKs, which in turn
  activates the MAP kinase kinases, culminating in MAPK activation (JNK, ERK and p38),
  and activates p38 and JNK. These terminal kinases then proceed to phosphorylate
  transcription factors within the nucleus, as well as other regulatory proteins in
  the nucleus. And also K63 polyubiquitination chains of NEMO increases the activity
  of IKK complex which leads to IκBα‐dependent activation of NF‐κB pathway. The TNF‐α
  pathway is regulated by deubiquitinases A20 and CYLD
pmcid: PMC6156430
papertitle: The role of K63‐linked polyubiquitination in cardiac hypertrophy.
reftext: Kaowen Yan, et al. J Cell Mol Med. 2018 Oct;22(10):4558-4567.
pmc_ranked_result_index: '16485'
pathway_score: 0.955355
filename: JCMM-22-4558-g002.jpg
figtitle: Schematic diagram of the molecular mechanisms underlying K63‐linked polyubiquitination
  and cardiac hypertrophy
year: '2018'
organisms: Homo sapiens
ndex: fe1390eb-deea-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6156430__JCMM-22-4558-g002.html
  '@type': Dataset
  description: A schematic diagram of the molecular mechanisms underlying K63‐linked
    polyubiquitination and cardiac hypertrophy. In TNF‐α pathway, TNFR recruits its
    adaptor protein TRADD in response to binding of TNF‐α. TRADD further recruits
    TRAF2, TRAF5 and RIP1 to the receptor complex. TRAF2/5‐mediated K63 polyubiquitination
    of RIP1 further recruits TAB2 and TAK1 in the cytoplasm, which activates TAK1
    by phosphorylation. The activated RIP1‐TAK1‐TAB2 complex subsequently promotes
    activation of MEKKs, which in turn activates the MAP kinase kinases, culminating
    in MAPK activation (JNK, ERK and p38), and activates p38 and JNK. These terminal
    kinases then proceed to phosphorylate transcription factors within the nucleus,
    as well as other regulatory proteins in the nucleus. And also K63 polyubiquitination
    chains of NEMO increases the activity of IKK complex which leads to IκBα‐dependent
    activation of NF‐κB pathway. The TNF‐α pathway is regulated by deubiquitinases
    A20 and CYLD
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MAPK9
  - MAPK11
  - MAPK13
  - MAPK12
  - MAPK14
  - CHUK
  - IKBKB
  - MAPK8
  - BIRC3
  - NFKB1
  - TRAF5
  - MAP2K6
  - IKBKG
  - DUOX1
  - RAC1
  - NCF1
  - CYBA
  - TRADD
  - TRAF2
  - MAP2K3
  - NOX5
  - BIRC2
  - CYBB
  - TNFAIP3
  - NOX3
  - TAB3
  - DUOX2
  - NOX4
  - KRR1
  - HESX1
  - TNF
  - TNFRSF1A
  - TAB2
  - SLC33A1
  - NCF4
  - NOX1
  - NCF2
  - NADPH
  - PolyUb
genes:
- word: JNK1/2
  symbol: JNK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: IKKA
  symbol: IKK-alpha
  source: hgnc_alias_symbol
  hgnc_symbol: CHUK
  entrez: '1147'
- word: IKKB
  symbol: IKK-beta
  source: hgnc_alias_symbol
  hgnc_symbol: IKBKB
  entrez: '3551'
- word: JNK1/2
  symbol: JNK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: CIAP1/2
  symbol: c-IAP2
  source: hgnc_alias_symbol
  hgnc_symbol: BIRC3
  entrez: '330'
- word: NF-kB
  symbol: NF-kappaB
  source: hgnc_alias_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: TRAF2/5
  symbol: TRAF5
  source: hgnc_symbol
  hgnc_symbol: TRAF5
  entrez: '7188'
- word: MKK3/6
  symbol: MKK6
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K6
  entrez: '5608'
- word: NEMO
  symbol: NEMO
  source: hgnc_alias_symbol
  hgnc_symbol: IKBKG
  entrez: '8517'
- word: NADPHoxidase
  symbol: NADPH_oxidase
  source: bioentities_symbol
  hgnc_symbol: DUOX1
  entrez: '53905'
- word: NADPHoxidase
  symbol: NADPH_oxidase
  source: bioentities_symbol
  hgnc_symbol: RAC1
  entrez: '5879'
- word: NADPHoxidase
  symbol: NADPH_oxidase
  source: bioentities_symbol
  hgnc_symbol: NCF1
  entrez: '653361'
- word: NADPHoxidase
  symbol: NADPH_oxidase
  source: bioentities_symbol
  hgnc_symbol: CYBA
  entrez: '1535'
- word: TRADD
  symbol: TRADD
  source: hgnc_symbol
  hgnc_symbol: TRADD
  entrez: '8717'
- word: TRAF2/5
  symbol: TRAF2
  source: hgnc_symbol
  hgnc_symbol: TRAF2
  entrez: '7186'
- word: MKK3/6
  symbol: MKK3
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K3
  entrez: '5606'
- word: NADPHoxidase
  symbol: NADPH_oxidase
  source: bioentities_symbol
  hgnc_symbol: NOX5
  entrez: '79400'
- word: CIAP1/2
  symbol: c-IAP1
  source: hgnc_alias_symbol
  hgnc_symbol: BIRC2
  entrez: '329'
- word: NADPHoxidase
  symbol: NADPH_oxidase
  source: bioentities_symbol
  hgnc_symbol: CYBB
  entrez: '1536'
- word: A20
  symbol: A20
  source: hgnc_alias_symbol
  hgnc_symbol: TNFAIP3
  entrez: '7128'
- word: NADPHoxidase
  symbol: NADPH_oxidase
  source: bioentities_symbol
  hgnc_symbol: NOX3
  entrez: '50508'
- word: TAB2/3
  symbol: TAB3
  source: hgnc_symbol
  hgnc_symbol: TAB3
  entrez: '257397'
- word: NADPHoxidase
  symbol: NADPH_oxidase
  source: bioentities_symbol
  hgnc_symbol: DUOX2
  entrez: '50506'
- word: NADPHoxidase
  symbol: NADPH_oxidase
  source: bioentities_symbol
  hgnc_symbol: NOX4
  entrez: '50507'
- word: RIP1
  symbol: RIP-1
  source: hgnc_alias_symbol
  hgnc_symbol: KRR1
  entrez: '11103'
- word: ANF
  symbol: ANF
  source: hgnc_alias_symbol
  hgnc_symbol: HESX1
  entrez: '8820'
- word: TNF-a
  symbol: TNF-alpha
  source: hgnc_alias_symbol
  hgnc_symbol: TNF
  entrez: '7124'
- word: TNFR
  symbol: TNF-R
  source: hgnc_alias_symbol
  hgnc_symbol: TNFRSF1A
  entrez: '7132'
- word: TAB2/3
  symbol: TAB2
  source: hgnc_symbol
  hgnc_symbol: TAB2
  entrez: '23118'
- word: AT1
  symbol: AT-1
  source: hgnc_alias_symbol
  hgnc_symbol: SLC33A1
  entrez: '9197'
- word: NADPHoxidase
  symbol: NADPH_oxidase
  source: bioentities_symbol
  hgnc_symbol: NCF4
  entrez: '4689'
- word: NADPHoxidase
  symbol: NADPH_oxidase
  source: bioentities_symbol
  hgnc_symbol: NOX1
  entrez: '27035'
- word: NADPHoxidase
  symbol: NADPH_oxidase
  source: bioentities_symbol
  hgnc_symbol: NCF2
  entrez: '4688'
chemicals:
- word: NADPH
  source: MESH
  identifier: D009249
- word: PolyUb
  source: MESH
  identifier: C110770
diseases: []
---
